Vitamin D: Metabolism, molecular mechanisms, and mutations to malignancies

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular Carcinogenesis

• Publication date

  2014-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.21999PMID 23359295
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D and aging.

  2013cited by this paper
• The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes.

  2012cited by this paper
• Does vitamin D protect against DNA damage?

  2012influential reference
• Association of genetic variants of the vitamin D receptor (VDR) with cutaneous squamous cell carcinomas (SCC) and basal cell carcinomas (BCC): a pilot study in a German population.

  2012influential reference
• 1.011 CIRCULATING VITAMIN D LEVELS, VITAMIN D BINDING PROTEIN GENE POLYMORPHISMS, AND SEVERITY OF PARKINSON'S DISEASE

  2012cited by this paper
• 25‐hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease

  2012cited by this paper
• Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives.

  2012cited by this paper
• Management of inflammatory bowel disease with vitamin D: beyond bone health.

  2012cited by this paper
• Vitamin and minerals that influence genome integrity, and exposure/intake levels associated with DNA damage prevention.

  2012cited by this paper
• Ethnic dress, vitamin D intake, and calcaneal bone health in young women in the United Kingdom.

  2012cited by this paper
• The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer

  2011cited by this paper
• Calcitriol stimulates prolactin expression in non-activated human peripheral blood mononuclear cells: breaking paradigms.

  2011cited by this paper
• The effects of vitamin D on brain development and adult brain function.

  2011cited by this paper
• Vitamin D metabolism in mammary gland and breast cancer.

  2011cited by this paper
• Vitamin D effects on lung immunity and respiratory diseases.

  2011cited by this paper
• Vitamin D and type 2 diabetes mellitus: where do we stand?

  2011cited by this paper
• Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer.

  2011cited by this paper
• The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial

  2011cited by this paper
• Angiogenesis and host immune response contribute to the aggressive character of non‐melanoma skin cancers in renal transplant recipients

  2011influential reference
• Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.

  2011cited by this paper
• Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase.

  2011cited by this paper
• Vitamin D: an ancient hormone

  2011cited by this paper
• Cytochromes P450 are essential players in the vitamin D signaling system.

  2011cited by this paper
• The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells.

  2011cited by this paper
• Assessment of evidence for a protective role of vitamin D in multiple sclerosis.

  2011cited by this paper
• Meta-analysis: serum vitamin D and breast cancer risk.

  2010cited by this paper
• CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma

  2010cited by this paper
• Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.

  2010cited by this paper
• Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system.

  2010cited by this paper
• Conversion of vitamin D3 to hormonally active 1alpha,25-dihydroxyvitamin D3 in cultured keratinocytes: relevance to cell growth and differentiation.

  2010cited by this paper
• Cutaneous vascular patterns in psoriasis

  2010cited by this paper
• Vitamin D and the immune system: new perspectives on an old theme.

  2010cited by this paper
• Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development.

  2010cited by this paper
• Skin Malignancy

  2010cited by this paper
• Taking treatment decisions in non-melanoma skin cancer--the place for topical photodynamic therapy (PDT).

  2010cited by this paper
• Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.

  2010cited by this paper
• Peroxisome proliferator-activated receptor (PPAR) and vitamin D receptor (VDR) signaling pathways in melanoma cells: Promising new therapeutic targets?

  2010cited by this paper
• 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.

  2010cited by this paper
• Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers.

  2010cited by this paper
• Vitamin D: modulator of the immune system.

  2010cited by this paper
• Regulation of keratinocyte signaling and function via changes in epidermal growth factor presentation.

  2010cited by this paper
• Photoprotection by 1alpha,25-dihydroxyvitamin D and analogs: further studies on mechanisms and implications for UV-damage.

  2010cited by this paper
• Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells.

  2010cited by this paper
• Direct epithelial-stromal interaction in corneal wound healing: Role of EMMPRIN/CD147 in MMPs induction and beyond.

  2009cited by this paper
• Characterization of the vitamin D endocrine system in human sebocytes in vitro.

  2009cited by this paper
• 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter.

  2009influential reference
• Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis.

  2009cited by this paper
• Increased UVA exposures and decreased cutaneous Vitamin D(3) levels may be responsible for the increasing incidence of melanoma.

  2009cited by this paper
• Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.

  2009cited by this paper
• Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro.

  2009cited by this paper
• Vitamin D, nervous system and aging.

  2009cited by this paper
• Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men

  2009cited by this paper
• Review Article: Vitamin D Acquisition and Breast Cancer Risk

  2009cited by this paper
• Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe.

  2009cited by this paper
• Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

  2009cited by this paper
• Regulatory role of 1, 25-dihydroxyvitamin D3 and vitamin D receptor gene variants on intracellular granzyme A expression in pulmonary tuberculosis.

  2009cited by this paper
• Role of the vitamin D3 pathway in healthy and diseased skin – facts, contradictions and hypotheses

  2009cited by this paper
• Vitamin D and aging.

  2009cited by this paper
• The vitamin D pathway: a new target for control of the skin’s immune response?

  2008cited by this paper
• Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities.

  2008cited by this paper
• Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D.

  2008cited by this paper
• Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

  2007cited by this paper
• Vitamin D and calcium supplementation reduces cancer risk : results of a randomized trial 1 , 2

  2007cited by this paper
• Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis.

  2007cited by this paper
• 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells.

  2007influential reference
• 1α,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases

  2007influential reference
• Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D.

  2007cited by this paper
• Clusterin over-expression modulates proapoptotic and antiproliferative effects of 1,25(OH)2D3 in prostate cancer cells in vitro.

  2007cited by this paper
• Vitamin D in rheumatoid arthritis.

  2007cited by this paper
• Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening, and hypertension.

  2007cited by this paper
• Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.

  2007cited by this paper
• Topically Applied 1,25-Dihydroxyvitamin D3 Enhances the Suppressive Activity of CD4+CD25+ Cells in the Draining Lymph Nodes1

  2007cited by this paper
• Interrelationship among 25hydroxyvitamin D (25HOD), parathyroid hormone (PTH) and bone remodeling in institutionalized women over 65 from lleida city (Spain) and suburban buenos aires (Argentina)

  2007cited by this paper
• DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27

  2007cited by this paper
• Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.

  2007influential reference
• 1α,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells

  2007cited by this paper
• In vivo relevance for photoprotection by the vitamin D rapid response pathway.

  2007cited by this paper
• Calcitriol inhibits hepatocyte apoptosis in rat allograft by regulating apoptosis-associated genes.

  2007cited by this paper
• Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?

  2007cited by this paper
• Keratinocyte proliferation, differentiation, and apoptosis--differential mechanisms of regulation by curcumin, EGCG and apigenin.

  2007cited by this paper
• Selective vitamin D receptor modulators and their effects on colorectal tumor growth.

  2007cited by this paper
• 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1α-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer

  2006cited by this paper
• HaCaT keratinocyte migration is dependent on epidermal growth factor receptor signaling and glycogen synthase kinase-3alpha.

  2006cited by this paper
• Who, what, where and when-influences on cutaneous vitamin D synthesis.

  2006cited by this paper
• High prevalence of vitamin D inadequacy and implications for health.

  2006cited by this paper
• Vitamin D: its role in cancer prevention and treatment.

  2006cited by this paper
• Vitamin D physiology.

  2006cited by this paper
• Vitamin D signaling is modulated on multiple levels in health and disease.

  2006cited by this paper
• Effects of delayed psychosocial interventions versus early psychosocial interventions for women with early stage breast cancer.

  2006cited by this paper
• 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.

  2006cited by this paper
• Vitamin D and skin cancer: a problem in gene regulation.

  2005cited by this paper
• Vitamin D–induced up–regulation of tumour necrosis factor alpha (TNF–α) in prostate cancer cells

  2005cited by this paper
• Vitamin D compounds in leukemia.

  2005cited by this paper
• P12 Analysis of 25-hydroxyvitamin d3-1a-hydroxylase in normal and malignant breast tissue

  2005cited by this paper
• Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.

  2005cited by this paper
• 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage.

  2005cited by this paper
• Photochemoprevention of ultraviolet B signaling and photocarcinogenesis.

  2005cited by this paper
• CHAPTER 92 – Differentiation and the Cell Cycle

  2005cited by this paper
• Tumor-stroma interactions: their role in the control of tumor cell invasion.

  2005cited by this paper
• Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs.

  2005cited by this paper

• Vitamin D as a Systemic Regulatory Axis: From Homeostasis to Multiorgan Disease

  2025cites this paper
• Evaluation of vitamin D3 levels and morphotic parameters of blood in prematurely born children at six years of age

  2019cites this paper
• High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer

  2019cites this paper
• Age-dependent expression of the vitamin D receptor and the protective effect of vitamin D receptor activation on H2O2-induced apoptosis in rat intervertebral disc cells.

  2019cites this paper
• 25-Hydroxyvitamin D serum levels and melanoma risk: a case–control study and evidence synthesis of clinical epidemiological studies

  2018cites this paper
• Gender differences and typical nutrition concerns of the diets of preschool children – the results of the first stage of an intervention study

  2017cites this paper
• Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence

  2017cites this paper
• 25-Hydroxyvitamin D-1-α-hydroxylase in apoliporotein E knockout mice: The role of protecting vascular smooth muscle cell from calcification.

  2017cites this paper
• Genome instability in childhood obesity: A conceptual framework for an assessment, intervention and monitoring programme of inflammation and DNA damage in paediatric obesity

  2017cites this paper
• Genetic Polymorphisms of Vitamin D Metabolism Genes and Serum Level of Vitamin D in Colorectal Cancer

  2017cites this paper
• Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer

  2016cites this paper
• 1,25-Dihydroxyvitamin D3 modulates calcium transport in goat mammary epithelial cells in a dose- and energy-dependent manner

  2016influential citation
• Desensitization of HaCaT keratinocytes to vitamin D3 occurs via loss of REDD1 regulation of the mTOR pathway

  2015cites this paper
• Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma

  2015cites this paper
• Understanding the physiology, pharmacology and therapeutic uses of vitamin D

  2014cites this paper
• Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK

  2014cites this paper
• Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients

  2013cites this paper
• The physiology and pharmacology of vitamin D

  2013cites this paper
• Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases.

  2013cites this paper